
Pick one or more. We'll use your choices and the connected bills to help you send a message to your elected officials.
Answer the policy questions below or skip any that don't fit your view. We use only your answers and the bills they connect to for your message.
1 bill on this topic
“Some compounded medicines should have a clear label saying they were compounded for an individual patient and have not been approved by FDA.”
1 bill on this topic
“Compounders should be limited to making 20 compounded versions in one month of a drug already sold in the United States, unless a prescriber says a specific patient needs a meaningful change.”
1 bill on this topic
“Federal compounding rules should make clear that the National Formulary reference includes drug monographs and dietary supplement monographs when deciding which ingredients may qualify for compounding.”
1 bill on this topic
“Before using the urgent pharmacy or physician compounding pathway, prescribers should have to write that they tried and could not get a similar compounded drug from an FDA-registered outsourcing facility.”
1 bill on this topic
“A compounded drug should not be treated as an impermissible copy of a commercial product when it is changed for a specific patient and the prescriber says the change makes a significant difference for that patient.”
1 bill on this topic
“FDA should post annual public updates on its review of bulk drug substances that outsourcing facilities may use for compounding.”
One sentence is enough. Tell officials how this affects your family, work, bills, neighborhood, or values so the message sounds like you.
Example: My daughter's school closed twice last fall because of wildfire smoke.
Step 2 of 3 · Add your info next
Answer at least one question to continue